OSTX

OS Therapies Incorporated

AMEX: OSTX · HEALTHCARE · BIOTECHNOLOGY

$1.71

+2.78% today

Updated 2026-06-04

Market cap

$77.50M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.07

Dividend yield

—

52W range

$1 – $3

Volume

0.8M

Market cap

$77.50M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.07

Dividend yield

—

52W range

$1 – $3

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-29.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$9.40

+449.71%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity -137.69x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -29.63 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-4.56M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-6.25M	$-7.79M	$-8.88M	$-28.75M	$-10.40M
EPS	—	—	—	—	$-1.07
Free cash flow	$-3.79M	$-3.01M	$-7.28M	$-14.24B	$-4.56M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OSTX	$77.50M	16	4.3	3.0	5.0	4.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

OS Therapies Incorporated trades at $1.71. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -29.63, it sits in the distress.

Frequently asked questions

What is OS Therapies Incorporated's stock price?

OS Therapies Incorporated (OSTX) trades at $1.71.

Is OS Therapies Incorporated overvalued?

OS Therapies Incorporated carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of OS Therapies Incorporated (OSTX)?

The 12-month analyst consensus target is $9.40, about 449.7% above the current $1.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

OS Therapies Incorporated's Altman Z-Score is -29.63, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeAMEX

CurrencyUSD

ostherapies.com

Quick metrics

P/S ratio—

ROE-914.00%

Beta—

50D MA$1.62

200D MA$1.70

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OSTX vs LLY →OSTX vs JNJ →OSTX vs ABBV →Stock screener →